Cargando…
The Evaluation of Drug Innovativeness in Italy: Key Determinants and Internal Consistency
BACKGROUND: Innovative medicines are provided with dedicated funds and immediate market access in Italy. Innovativeness evaluation considers unmet need, added therapeutic value, and quality of the evidence. OBJECTIVE: We aimed to evaluate the internal consistency and drivers of the innovativeness ap...
Autores principales: | Jommi, Claudio, Galeone, Carlotta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169980/ https://www.ncbi.nlm.nih.gov/pubmed/36763319 http://dx.doi.org/10.1007/s41669-023-00393-3 |
Ejemplares similares
-
Key drivers of innovativeness appraisal for medicines: the Italian experience after the adoption of the new ranking system
por: Galeone, Carlotta, et al.
Publicado: (2021) -
The Economic Impact of a Switch From Prescription-Only to Non-prescription Drugs in Italy
por: Otto, Monica Hildegard, et al.
Publicado: (2018) -
Corrigendum: The Economic Impact of a Switch From Prescription-Only to Non-prescription Drugs in Italy
por: Otto, Monica Hildegard, et al.
Publicado: (2019) -
Protocol Implementation for Normothermia in Surgery Settings in Italy: Budget-Impact Analysis
por: Monzani, Roberta, et al.
Publicado: (2020) -
The simultaneous effects of pharmaceutical policies from payers’ and patients’ perspectives: Italy as a case study
por: Armeni, Patrizio, et al.
Publicado: (2015)